About Somite Therapeutics
Somite Therapeutics is a private company based in Boston, Massachusetts, incorporated in 2023 in Delaware. It has reported $47,499,943 raised in one offering on Form D since November 2025. Its chief executive is Micah Breakstone.
Funding Rounds (SEC Form D)
| First sale | Filed with SEC | Amount sold | Investors | Avg. check | Terms | Filing |
|---|---|---|---|---|---|---|
| Apr 11, 2025 | Nov 26, 2025 | $47,499,943fully sold | 30 | $1.5M | EquityRule 506(b) | Form D ↗ |
First sale is the date the first investor in the offering committed to invest. Companies must file Form D within 15 days of that date, so filing dates run later.
Leadership Team
Executive officers and directors listed on Somite Therapeutics's Form D filed Nov 26, 2025.